Editorial Comment to Real-World Occurrence of Adverse Events Associated With Adjuvant Pembrolizumab Therapy for Renal

Hajime Tanaka1

  • 1Department of Urology, Institute of Science Tokyo, Tokyo, Japan.

Abstract

No abstract available in PubMed .